Pancreatic bleedingDiagnozė
Bleeding through the pancreatic duct can be difficult to locate, especially when it stops and starts. Learn which symptoms need emergency care and how specialists investigate the source.
Mediciniškai peržiūrėjo Tomas Kleinas, MD
Svarbiausios išvados
- Apibrėžimas: Hemosuccus pancreaticus is gastrointestinal bleeding that enters the pancreatic duct and flows into the small intestine.
- Emergency signs: Vomiting blood, black tarry stool, fainting, or severe weakness can signal a dangerous bleed; seek emergency care immediately.
- Intermittent bleeding: A first endoscopy can miss the source if bleeding has stopped or the duct opening is not clearly seen.
- Common setting: Pancreatitis and a nearby arterial pseudoaneurysm are recognized causes, but not everyone has a known pancreatic condition.
- Vaizdiniai tyrimai: CT angiography can identify an abnormal artery or active bleeding; a negative scan does not always exclude an intermittent bleed.
- Specialist treatment: Catheter angiography can both locate an arterial source and allow embolization to stop it.
- Blood tests: Hemoglobin helps assess anemia, but an early result can be normal and cannot identify the bleeding site.
- Stool tests: A positive or negative stool blood test cannot establish whether blood came from the pancreatic duct.
What happens in hemosuccus pancreaticus?
Hemosuccus pancreaticus occurs when blood enters the pancreatic duct and passes through its opening into the duodenum, the first part of the small intestine. It is a rare cause of gastrointestinal bleeding.

The pancreas sits behind the stomach and makes digestive enzymes. Its main duct normally carries these enzymes to the duodenum through an opening called the major papilla.
A damaged artery near the pancreas can connect with the duct, sometimes through a pancreatic fluid collection. Blood then follows the duct into the digestive tract rather than appearing at an obvious ulcer on the stomach lining.
Kitos priežastys kraujas išmatose are much more common. Symptoms alone cannot establish that the pancreas is the source.
What are the symptoms of hemosuccus pancreaticus?
Hemosuccus pancreaticus symptoms can include black tarry stools, upper abdominal pain, weakness, dizziness, or vomiting blood. Some people have recurrent episodes separated by symptom-free intervals.

Black, sticky stool with a strong odor is called melena and can occur when blood is digested as it travels through the gut. Iron tablets and some medicines can also darken stool, but a new tarry stool needs urgent assessment.
Abdominal pain may accompany bleeding, although not every patient has pain. A clot within the pancreatic duct may obstruct drainage and contribute to discomfort, but pain alone does not establish the diagnosis.
Heavy gastrointestinal bleeding can occasionally cause bright red or maroon stool rather than black stool. For comparison, other digestive symptoms have different possible causes and do not identify a pancreatic source.
Which symptoms require emergency care?
Vomiting blood or material resembling coffee grounds, passing black tarry stool, fainting, or experiencing severe weakness with suspected bleeding requires immediate emergency evaluation. Call emergency services if the person is collapsing, confused, short of breath, or unable to travel safely.

Do not drive yourself if you feel faint, and do not wait for a stool test or an AI interpretation. A bleed that seems to stop can restart and become life-threatening.
Tell the emergency team about previous pancreatitis, pancreatic fluid collections, procedures, and any blood-thinning medicines. Bring a medication list if it is immediately available, but do not delay getting help to find it.
Fresh rectal bleeding also needs prompt medical assessment; a large amount, dizziness, fainting, or severe abdominal pain makes it an emergency. Our guide to kraujas išmatose explains why a positive screening result still needs a clinician-led investigation.
What causes bleeding from the pancreatic duct?
Bleeding from the pancreatic duct often results from an arterial pseudoaneurysm associated with pancreatitis or a pancreatic fluid collection. Less common causes include trauma, pancreatic tumors, and complications of procedures.

A pseudoaneurysm is a contained leak from an artery, not simply a widened artery with all its usual wall layers intact. Pancreatic inflammation and enzymes can weaken a nearby vessel, allowing a fragile blood-filled cavity to form.
The splenic artery is a recognized source because it runs close to the pancreas, although other nearby arteries can be involved. The precise vessel matters because an interventional radiologist plans treatment around its anatomy.
A review by Tarar and colleagues describes pancreatitis, pseudoaneurysms, and pseudocysts among the clinical settings associated with this condition (Tarar et al., 2022). In a separate diagnostic context, an IgG4 result cannot by itself establish pancreatic disease or a bleeding source.
Why can bleeding stop and restart?
Hemosuccus pancreaticus can be intermittent because clots or temporary changes in flow may interrupt the passage of blood into the pancreatic duct. Symptoms can settle even though the underlying vessel remains at risk.

An examination performed between episodes may show no active blood at the papilla. That makes the timing of symptoms useful clinical information, not a reason to wait for another episode before seeking care.
For a hypothetical example, a person with prior pancreatitis has black stools on Monday and a normal-looking initial endoscopy on Tuesday. If symptoms recur, the team may reassess the pancreatic vessels rather than assume the first examination excluded every source.
A record of when stool changed, whether pain accompanied it, and any prior imaging can help clinicians compare events with investigations. Avoid self-testing during a suspected emergency; stool blood testing has a different purpose.
Why can an initial endoscopy miss the source?
An initial upper endoscopy can miss hemosuccus pancreaticus if bleeding is not active or the major papilla is difficult to inspect. A normal-looking stomach and duodenum therefore do not rule out a pancreatic duct source.

A standard upper endoscope examines the esophagus, stomach, and duodenum. It is valuable because ulcers and other more common upper gastrointestinal sources may be visible and treatable during the same procedure.
The papilla sits on the wall of the duodenum and may not be well seen with a forward-viewing scope. A side-viewing endoscope can provide a better view when specialists consider it appropriate, but it still may miss bleeding that has stopped.
Seeing blood emerge from the papilla can provide a strong clue, although clinicians must also consider blood coming from the bile duct. Other gastrointestinal diagnoses can likewise require a specific technique, as explained in our article on endoscopy and biopsy.
How does CT angiography help diagnosis?
CT angiography, or CTA, uses contrast and timed CT images to examine blood vessels and may show a pseudoaneurysm or active contrast leakage. It can also reveal pancreatitis, a fluid collection, or blood within the pancreatic duct.

A multiphase study captures images at different times after contrast injection. The phases help a radiologist distinguish vessel anatomy from contrast that has escaped into nearby tissue or a duct.
A negative CTA does not exclude intermittent hemorrhage, particularly when there is no active flow at the time of imaging. A visible pseudoaneurysm may still be clinically significant even when active leakage is not seen.
The team considers contrast allergy and kidney function when choosing imaging, but potentially life-saving investigation should not be delayed without a clinical reason. BUN ir kreatininas provide context about kidney function; neither test locates gastrointestinal bleeding.
What does catheter angiography add?
Catheter angiography maps arteries using contrast delivered through a small catheter and can identify a pancreatic arterial source. When an appropriate vessel is found, the same procedure can often treat it.

An interventional radiologist guides the catheter into selected arteries and takes images of the vessel network. The examination may reveal a pseudoaneurysm or active leakage, but intermittent bleeding can also make angiography negative.
A coil or another embolic material may be placed to block the responsible vessel. The choice depends on the artery, its branches, and the need to preserve circulation to nearby organs.
The team weighs procedure-related risks, including reduced blood supply to surrounding tissue, against the danger of continued bleeding. A crossmatch before transfusion may be needed as part of the broader emergency plan.
When are endoscopic ultrasound and ERCP used?
Endoscopic ultrasound and ERCP can provide additional information when the diagnosis remains uncertain, but neither replaces urgent stabilization or vascular imaging when a serious arterial bleed is suspected.

Endoscopic ultrasound places an ultrasound probe close to the pancreas from inside the digestive tract. Doppler imaging may help assess a nearby vessel or a pancreatic fluid collection, depending on the clinical question and local expertise.
ERCP, or endoscopic retrograde cholangiopancreatography, uses an endoscope and contrast to examine or treat selected pancreatic and bile duct problems. It is invasive and can cause pancreatitis or other complications, so specialists select it for a specific reason.
Finding a duct abnormality does not automatically prove it caused a bleed. Imaging findings and symptoms must be considered together, much as a pancreatic marker result requires clinical context.
Which blood tests help assess a suspected bleed?
A complete blood count, blood group and compatibility testing, kidney function tests, and clotting tests help clinicians assess and prepare for gastrointestinal bleeding. None can independently diagnose hemosuccus pancreaticus.

Hemoglobin measures the oxygen-carrying protein in red cells. After sudden blood loss, the first value may not yet show the eventual fall, so the team interprets repeat results alongside pulse, blood pressure, symptoms, and treatment.
In the American College of Gastroenterology guideline for hospitalized upper gastrointestinal bleeding, a hemoglobin threshold of 7 g/dL is suggested for transfusion in many patients (Laine et al., 2021). That is not a home-care cutoff: active bleeding, shock, heart disease, and other circumstances require individualized decisions.
Kantesti yra AI kraujo tyrimo analizatorius that can help explain reported hemoglobin and other CBC values after urgent care has been arranged. It cannot assess circulation, replace repeat testing, or find a pancreatic vessel; see our explanation of hemoglobin and hematocrit.
Can a stool test identify pancreatic duct bleeding?
No routine stool test can identify the pancreatic duct as the source of bleeding. A fecal occult blood test or FIT may detect blood in some circumstances, but it cannot show where that blood originated.

FIT detects human hemoglobin and is mainly used in specific screening or assessment pathways for lower gastrointestinal bleeding. Blood from an upper source may be digested before it reaches the stool, so a negative FIT cannot safely rule out an upper gastrointestinal bleed.
A positive screening test needs follow-up for its own reasons; it does not prove pancreatic bleeding or cancer. Visible black tarry stool or vomiting blood warrants urgent clinical assessment rather than a home screening kit.
Stool inflammation tests answer a different question again. Our comparison of kalprotektinas ir laktiferinas explains why markers of intestinal inflammation do not localize an arterial bleed.
How is hemosuccus pancreaticus treated?
Treatment combines resuscitation with a plan to control the bleeding source, often using catheter embolization when the anatomy allows. Surgery may be necessary if embolization fails, is unsuitable, or another pancreatic problem also needs an operation.

In hospital, clinicians monitor vital signs, establish intravenous access, and give fluids or blood products when needed. They also review anticoagulants and other medicines that can affect bleeding, balancing reversal against each person's clotting risk.
Embolization can stop flow through the affected artery without open surgery. Repeat imaging or another intervention may be needed if bleeding returns, because the initial procedure does not guarantee permanent control.
. Normalus clotting panel does not rule out a damaged artery. Do not stop a prescribed anticoagulant independently unless the treating emergency team directs you to do so.
What follow-up is needed after treatment?
Follow-up after hemosuccus pancreaticus focuses on recurrent bleeding, recovery from anemia, and the pancreatic or vascular problem that caused the event. The schedule depends on the intervention and the person's condition.

Before leaving hospital, ask which symptoms should trigger emergency care and whom to contact about non-emergency questions. New vomiting of blood, black tarry stool, fainting, or marked weakness should not wait for a scheduled appointment.
Repeat hemoglobin and, when appropriate, iron studies can help track recovery. Low ferritin may suggest depleted iron stores, but inflammation can complicate its interpretation; our geležies tyrimų vadovas explains the related markers.
Kantesti yra AI kraujo tyrimo rezultatų interpretavimo platforma that can help organize follow-up laboratory results for discussion with a clinician. Its atsakingo DI informacija explains why an automated interpretation is not a substitute for clinical decisions.
What should you ask your care team?
Ask your care team whether a source has been confirmed, whether a pancreatic vessel or fluid collection was seen, and what to do if bleeding returns. These questions clarify both the current diagnosis and the plan if uncertainty remains.

Useful questions include: “Was the papilla seen during endoscopy?”, “Did the scan show a pseudoaneurysm?”, and “Would repeat imaging or specialist review be appropriate if symptoms recur?” The answers depend on the actual examination and your clinical stability.
If treatment was performed, ask which vessel was treated, whether further imaging is planned, and when medicines can safely be resumed. Keep copies of the discharge summary and imaging reports available for future emergency visits.
Kantesti can support discussion of laboratory trends, but it cannot confirm a bleeding source or advise you to delay care. Our medicininio turinio standartai describe the approach used for health information on the site.
Dažnai užduodami klausimai
Ar hemosuccus pancreaticus yra skubios medicinos pagalbos reikalaujanti būklė?
Hemosuccus pancreaticus gali būti gyvybei pavojinga skubi būklė, nes pažeista arterija gali gausiai kraujuoti arba kraujavimas gali atsinaujinti. Įtarus kraujavimą, būtina nedelsiant kreiptis skubiosios pagalbos, jei vemiama krauju, tuštinamasi juodomis, deguto pavidalo išmatomis, alpstama arba jaučiamas didelis silpnumas. Nelaukite antro kraujavimo epizodo ar išmatų tyrimo ir nedelsdami kreipkitės pagalbos.
Ar endoskopija gali nepastebėti hemosukkus pankreatikus?
Taip. Atliekant viršutinę endoskopiją gali nepavykti aptikti hemosuccus pancreaticus, jei kraujavimas liovėsi arba kasos latako anga nėra aiškiai matoma. Atsižvelgdamas į aplinkybes, gydytojas gali apsvarstyti tyrimą šoninio vaizdo endoskopu, KT angiografiją arba kitą specializuotą tyrimą. Vienas neigiamas tyrimo rezultatas nebūtinai paneigia protarpinį kraujavimą.
Koks tyrimas naudingiausias įtarus hemosuccus pancreaticus?
KT angiografija dažnai naudinga, nes gali parodyti kasos pseudoaneurizmą, aktyvų kontrastinės medžiagos nuotėkį ir susijusius kasos pakitimus. Kateterinė angiografija gali suteikti išsamesnius arterijų vaizdus ir taip pat sudaryti galimybę taikyti gydymą. Bet kurio tyrimo rezultatas gali būti neigiamas, jei kraujavimas yra protarpinis, todėl gydytojai jį vertina atsižvelgdami į simptomus ir kitus radinius.
Ar normalus hemoglobino kiekis gali paneigti kraujavimą iš kasos latako?
No. Hemoglobin can initially remain in the reference range after sudden blood loss and cannot identify where bleeding originated. Clinicians may repeat a complete blood count and assess blood pressure, pulse, symptoms, and imaging. An emergency transfusion decision is based on the whole clinical picture, not one laboratory number alone.
Does a positive FIT diagnose hemosuccus pancreaticus?
No. A positive FIT detects human hemoglobin in stool but does not locate the source or diagnose hemosuccus pancreaticus. A negative FIT also cannot reliably exclude an upper gastrointestinal bleed, because blood may be digested before it reaches the stool. Visible bleeding or black tarry stool requires clinical assessment rather than waiting for a screening test.
Can hemosuccus pancreaticus be treated without surgery?
Hemosuccus pancreaticus can sometimes be treated without open surgery through catheter-directed embolization of the responsible artery. The approach depends on the vessel anatomy, the person's stability, and available expertise. Surgery remains an option when embolization is not feasible, fails, or another pancreatic problem requires an operation.
Sužinokite, kaip skaityti kraujo tyrimo rezultatus
Įkelkite laboratorinio tyrimo ataskaitą ir Kantesti AI per kelias sekundes paprasta kalba paaiškins kiekvieną biomarkerį. Juo naudojasi daugiau nei 2 milijonai žmonių visame pasaulyje.
Nuorodos
- Klein, T., Mitchell, S., & Weber, H. (2026). BUN/Creatininio santykio paaiškinimas: Nerų funkcijos testų vadovas. Kantesti AI medicininiai tyrimai. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). Urobilinogeno šlapimo testas: Pilnas šlapimo analizės vadovas 2026. Kantesti AI medicininiai tyrimai. DOI
- Tarar ZI et al. (2022). Hemosuccus Pancreaticus: A Comprehensive Review of Presentation, Diagnosis, and Management. Gastroenterology Research.
- Laine L et al. (2021). ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. American Journal of Gastroenterology. DOI
- 2M+Ištirti tyrimai
- 127+Šalys
- 100+Kalbos
Apie medicinos komandą

Tomas Kleinas, medicinos mokslų daktaras
Pagrindinis autorius · Medicininės dalies recenzentas
Vyriausiasis medicinos pareigūnas, Kantesti AI
Dr. Thomas Klein yra sertifikuotas klinikinis hematologas ir vidaus ligų gydytojas, turintis daugiau nei 15 metų patirtį laboratorinės medicinos ir dirbtinio intelekto padedamos klinikinės analizės srityse.

Sarah Mitchell, MD, PhD
Medicinos patarėjas
Vyriausiasis medicinos patarėjas – klinikinė patologija ir vidaus ligos
Dr. Sarah Mitchell yra sertifikuota klinikinė patologė, turinti daugiau nei 18 metų patirtį laboratorinės medicinos ir diagnostinės analizės srityje. Ji turi klinikinės chemijos specializacijos sertifikatus ir plačiai publikavo biomarkerių panelių bei laboratorinės analizės klausimais klinikinėje praktikoje.

Prof. Dr. Hans Weber, PhD
Prisidedantis ekspertas
Laboratorinės medicinos ir klinikinės biochemijos profesorius
Prof. Dr. Hans Weber turi 30+ metų patirtį klinikinėje biochemijoje, laboratorinėje medicinoje ir biomarkerių tyrimuose. Buvęs Vokietijos klinikinės chemijos draugijos prezidentas, jis specializuojasi diagnostinių panelių analizėje, biomarkerių standartizavime ir AI paremtos laboratorinės medicinos srityje.
E-E-A-T patikimumo signalai
Patirtis
Gydytojo vadovaujama klinikinė laboratorinių tyrimų interpretavimo darbo eigų peržiūra.
Ekspertizė
Laboratorinės medicinos dėmesys tam, kaip biomarkeriai elgiasi klinikiniame kontekste.
Autoritetas
Mediciniškai peržiūrėjo dr. Thomas Klein, prisidėjo dr. Sarah Mitchell ir prof. dr. Hans Weber.
Patikimumas
Įrodymais pagrįsta interpretacija su aiškiais tolesnių veiksmų keliais, siekiant sumažinti nerimą.
Skaityti toliau
Daugiau medicinos vadovų iš Kantesti medicinos komandos:

JAK2 mutacijos tyrimo rezultatai: ką reiškia teigiamas rezultatas
Supraskite teigiamus arba neigiamus JAK2 mutacijos tyrimo rezultatus, mažą alelio naštą ir 12 egzono radinius. Sužinokite, ką aptarti su…
Skaityti straipsnį →
Šlapimo porfobilinogeno mėginio tvarkymas: praktinis vadovas
Sužinokite, kaip šviesa, šlapimo praskiedimas ir mėginio paėmimo laikas veikia PBG tyrimo rezultatus ir kada dėl simptomų reikia skubios pagalbos. Sužinokite praktinių…
Skaityti straipsnį →
Okskarbazepino koncentracija: MHD intervalai, tyrimo laikas ir saugūs tolesni veiksmai
Supraskite okskarbazepino koncentraciją, kodėl laboratorijose matuojamas MHD ir kaip mėginio paėmimo laikas veikia rezultatus. Pasiruoškite klausimus, kad vaistus vartotumėte saugiau…
Skaityti straipsnį →
Pozakonazolo koncentracija: maži rezultatai, absorbcija ir tikslinės vertės
Mažas pozakonazolo kiekis gali rodyti prastą absorbciją, vaisto formą ar netinkamą tyrimo laiką, o ne praleistas dozes. Patikrinkite mažiausias koncentracijas ir ką…
Skaityti straipsnį →
Leflunomido pašalinimas iš organizmo prieš nėštumą: saugūs tyrimai
Suplanuokite leflunomido pašalinimą iš organizmo prieš nėštumą, nurodydami tikslias dozes, kraujo tyrimų ribines vertes ir laiko skirtumus tarp JK ir JAV. Sužinokite, ką reikia patvirtinti…
Skaityti straipsnį →
PFAPA sindromas: karščiavimo pobūdis, simptomai ir diagnozė
PFAPA sindromas sukelia pasikartojantį karščiavimą, burnos opas, gerklės skausmą ir kaklo limfmazgių padidėjimą. Sužinokite apie karščiavimo pobūdį, naudingus tyrimus ir…
Skaityti straipsnį →Sužinokite apie visus mūsų sveikatos gidus ir AI pagrįstus kraujo tyrimo rezultatų analizės įrankius adresu kanesti.net
Medicininė atsakomybės ribojimo nuostata
Šis straipsnis skirtas tik mokymo tikslais ir nesudaro medicininės konsultacijos. Visada kreipkitės į kvalifikuotą sveikatos priežiūros specialistą dėl diagnozės ir gydymo sprendimų.
Paskelbta · Susisiekite su redakcine komanda
Išleido Kantesti Ltd, registruota Anglijoje ir Velse, įmonės Nr. 17090423, Londonas, Jungtinė Karalystė.